NNG.WA
Price:
$2.8
Market Cap:
$90.06M
NanoGroup S.A. operates as a biotechnology company. It develops and licenses early-stage biotechnology and medical projects in the areas of oncology, transplantology, and blood donations to international biotech companies and pharmaceutical companies. NanoGroup S.A was incorporated in 2016 and is based in Warsaw, Poland.
Industry
Biotechnology
IPO Date
2018-03-14
Stock Exchange
WSE
Ticker
NNG.WA
According to NanoGroup S.A.’s latest financial reports and current stock price. The company's current ROE is -57.44%. This represents a change of 284.10% compared to the average of -14.95% of the last 4 quarters.
The mean historical ROE of NanoGroup S.A. over the last ten years is -44.61%. The current -57.44% ROE has changed 28.75% with respect to the historical average. Over the past ten years (40 quarters), NNG.WA's ROE was at its highest in in the December 2022 quarter at 43.09%. The ROE was at its lowest in in the December 2021 quarter at -87.98%.
Average
-44.61%
Median
-16.11%
Minimum
-176.24%
Maximum
-6.92%
Discovering the peaks and valleys of NanoGroup S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.39%
Maximum Annual ROE = -6.92%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -176.24%
| Year | ROE | Change |
|---|---|---|
| 2024 | -34.00% | -80.71% |
| 2023 | -176.24% | 1.39% |
| 2022 | -11.84% | -90.85% |
| 2021 | -129.37% | 340.05% |
| 2020 | -29.40% | 134.48% |
| 2019 | -12.54% | -23.96% |
| 2018 | -16.49% | 4.77% |
| 2017 | -15.74% | 127.34% |
| 2016 | -6.92% | -48.98% |
| 2015 | -13.57% | -Infinity% |
The current ROE of NanoGroup S.A. (NNG.WA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-74.03%
5-year avg
-76.17%
10-year avg
-44.61%
NanoGroup S.A.’s ROE is greater than Genomtec S.A. (-104.44%), greater than Urteste S.A. (-17.38%), greater than Pharmena S.A. (-15.06%), less than Pure Biologics Spólka Akcyjna (168.05%), greater than Poltreg S.A. (-37.19%), less than Medinice S.A. (55.26%), greater than Mabion S.A. (-32.43%), greater than Molecure S.A. (-32.20%), less than BioMaxima S.A. (1.49%), greater than Airway Medix S.A. (-9.25%),
| Company | ROE | Market cap |
|---|---|---|
| -104.44% | $65.83M | |
| -17.38% | $51.73M | |
| -15.06% | $33.97M | |
| 168.05% | $33.58M | |
| -37.19% | $122.18M | |
| 55.26% | $98.66M | |
| -32.43% | $126.07M | |
| -32.20% | $150.20M | |
| 1.49% | $48.22M | |
| -9.25% | $35.68M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NanoGroup S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NanoGroup S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is NanoGroup S.A.'s ROE?
How is the ROE calculated for NanoGroup S.A. (NNG.WA)?
What is the highest ROE for NanoGroup S.A. (NNG.WA)?
What is the 3-year average ROE for NanoGroup S.A. (NNG.WA)?
What is the 5-year average ROE for NanoGroup S.A. (NNG.WA)?
How does the current ROE for NanoGroup S.A. (NNG.WA) compare to its historical average?